Earth Science Tech Acquires Zoolzy to Strengthen Pharmaceutical Supply Chain and Enter Veterinary Market

Earth Science Tech, Inc. (OTC: ETST), a strategic holding company focused on a diversified portfolio, has announced the acquisition of Zoolzy LLC, a Doral, Florida-based wholesale distributor of active pharmaceutical ingredients (APIs) and finished FDA-approved prescription products. This move is expected to significantly bolster ETST's pharmaceutical supply chain, offering competitive wholesale pricing that could increase overall profit margins for its compounding pharmacies.

Zoolzy operates from a 3,684-square-foot facility and will be integrated into ETST's existing operations. The acquisition provides ETST with immediate access to a broader range of APIs, enabling more customized compounding solutions. Additionally, it opens doors to common veterinary medications, allowing ETST to expand into the animal health market with innovative, flavored, and easy-to-administer therapeutics. This initiative is led by management team members who bring experience and established networks in the exotic wildlife sector.

The strategic rationale behind this acquisition is multifaceted. By securing a direct supply of APIs, ETST can reduce costs and improve efficiency in its compounding operations, directly impacting profitability. The expansion into veterinary medicine represents a significant growth opportunity, as the animal health market is robust and continues to grow. ETST's management is leveraging its expertise to develop unique products tailored to pets and exotic animals, potentially capturing a niche market.

This acquisition aligns with ETST's broader strategy of building a vertically integrated healthcare platform. The company combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The integration of Zoolzy strengthens the supply chain component, ensuring that patients and veterinarians have access to high-quality medications at competitive prices. This vertical integration is designed to create synergies across subsidiaries, enhancing the overall value proposition.

The news of this acquisition has implications for investors and the healthcare sector. It signals ETST's commitment to growth and diversification, potentially increasing its competitiveness in the pharmaceutical and veterinary markets. By securing a reliable supply of APIs, ETST positions itself to better navigate supply chain disruptions and price fluctuations, which have been prevalent in the industry. Furthermore, the move into veterinary medicine could open new revenue streams and reduce reliance on traditional human pharmaceuticals.

For more information about Earth Science Tech, visit the company's newsroom at https://ibn.fm/ETST. The full press release can be accessed at https://ibn.fm/nHFqQ.